4D Molecular Therapeutics (FDMT) Current Ratio
Price: $3.34
Market Cap: $154.65M
Avg Volume: 827.34K
Market Cap: $154.65M
Avg Volume: 827.34K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
4D Molecular Therapeutics Current Ratio
- Annual: 14.92
- Quarterly: 14.92
- TTM: 14.92
What is the Current Ratio?
The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.
Related Metrics
Other important metrics to assess 4D Molecular Therapeutics's financial health include:
- Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
- Annual: 14.92
- Quarterly: 14.92
- TTM: 14.92
- Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
- Annual: 5.12
- Quarterly: 5.12
- TTM: 5.12
These metrics provide insights into 4D Molecular Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Current Ratio
14.92
Quarterly Current Ratio
14.92
TTM Current Ratio
14.92
4D Molecular Therapeutics Historical Current Ratio
Historical Quick Ratio
Historical Cash Ratio
4D Molecular Therapeutics Historical Ratios
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Current Ratio | Quick Ratio | Cash Ratio |
|---|---|---|---|
| 2024 | 14.92 | 14.92 | 5.12 |
| 2023 | 15.65 | 15.65 | 13.14 |
| 2022 | 14.02 | 14.39 | 13.90 |
| 2021 | 19.31 | 19.83 | 19.31 |
| 2020 | 16.88 | 16.88 | 16.53 |
| 2019 | 4.05 | 4.05 | 3.83 |
| 2018 | 11.68 | 11.68 | 11.39 |
| 2017 | 4.15 | 4.15 | 4.04 |
Related Metrics
Explore detailed financial metrics and analysis for FDMT.